Methylprednisolone

corticosteroid: A type of anti-inflammatory medication that mimics hormones naturally produced by the adrenal glands, used to reduce inflammation and suppress immune responses.

adrenal insufficiency: A condition where the adrenal glands don't produce enough cortisol, which can cause fatigue, low blood pressure, and weakness — can be triggered by stopping corticosteroids abruptly.

HPA axis suppression: The slowing down of the hypothalamic-pituitary-adrenal system, which regulates the body's own steroid hormone production, caused by long-term corticosteroid use.

immunosuppressive: Reducing or lowering the activity of the immune system, which can help in autoimmune diseases but also increases infection risk.

intra-articular: Injected directly into a joint space, such as a knee or shoulder, to deliver medication right where inflammation is occurring.

intralesional: Injected directly into a skin lesion or abnormal tissue area to treat it locally.

intramuscular: Injected into a muscle, allowing the medication to be absorbed gradually into the bloodstream.

intrathecal: Delivered into the fluid-filled space surrounding the spinal cord — methylprednisolone acetate injectable suspension is contraindicated by this route.

idiopathic thrombocytopenic purpura (ITP): A bleeding disorder where the immune system attacks platelets, causing low platelet counts and easy bruising or bleeding — intramuscular corticosteroids are contraindicated in this condition.

systemic lupus erythematosus: An autoimmune disease where the immune system attacks the body's own tissues, causing inflammation in multiple organs.

rheumatoid arthritis: An autoimmune disease causing chronic joint inflammation, pain, and eventual joint damage.

adrenocortical insufficiency: Failure of the adrenal cortex (outer layer of the adrenal glands) to produce adequate amounts of steroid hormones, particularly cortisol.

osteoporosis: A condition where bones become weak and brittle, increasing the risk of fractures — a known risk with long-term corticosteroid use.

posterior subcapsular cataracts: A type of clouding of the lens at the back of the eye, associated with long-term corticosteroid use, which can impair vision.

glaucoma: A group of eye conditions that damage the optic nerve, often due to increased pressure inside the eye — a possible side effect of corticosteroid use.

peptic ulcer: A sore that develops on the lining of the stomach or upper small intestine, which can be worsened by corticosteroids especially when combined with NSAIDs.

hypokalemia: Abnormally low potassium levels in the blood, which can affect heart and muscle function — a risk with corticosteroid and potassium-depleting drug combinations.

Cushing's syndrome: A condition caused by too much cortisol in the body — either from the body producing too much or from taking high doses of corticosteroids — causing weight gain, moon face, and other effects.

anaphylaxis: A severe, potentially life-threatening allergic reaction that can cause difficulty breathing, rapid pulse, and a dangerous drop in blood pressure.

pancreatitis: Inflammation of the pancreas, which can cause severe abdominal pain and is listed as a possible adverse reaction with corticosteroids.

avascular necrosis (aseptic necrosis): Death of bone tissue due to reduced blood supply — the femoral and humeral head (hip and shoulder joints) are at risk with corticosteroid use.

myasthenia gravis: An autoimmune disorder causing muscle weakness, where the interaction with corticosteroids and anticholinesterase drugs can cause severe weakness.

cyclosporine: An immunosuppressant drug often used after organ transplants or for autoimmune diseases; its activity can increase when taken with corticosteroids.

warfarin: A commonly used blood-thinning medication whose effectiveness can be reduced when taken alongside corticosteroids.

enzyme inducer: A drug that speeds up the activity of liver enzymes, causing other medications (like corticosteroids) to be broken down faster and potentially become less effective.

enzyme inhibitor: A drug that slows liver enzyme activity, causing medications like corticosteroids to be broken down more slowly and accumulate to higher levels.

live vaccine: A vaccine made from weakened but living virus or bacteria — people on immunosuppressive doses of corticosteroids should not receive these, as the weakened pathogen could cause infection.

NSAIDs: Nonsteroidal anti-inflammatory drugs (such as ibuprofen or aspirin) that relieve pain and inflammation — their combination with corticosteroids increases the risk of stomach bleeding.

tapering: The process of gradually reducing a medication dose over time rather than stopping abruptly, used with corticosteroids to allow the adrenal glands to recover.

pemphigus: A rare, serious autoimmune skin disease that causes blistering of the skin and mucous membranes.

mycosis fungoides: A type of slow-growing lymphoma (cancer of white blood cells) that primarily affects the skin.

nephrotic syndrome: A kidney disorder causing the kidneys to leak large amounts of protein into the urine, leading to swelling and other complications.

dermatomyositis: An inflammatory disease marked by muscle weakness and a distinctive skin rash, classified as an autoimmune condition.

ankylosing spondylitis: A type of arthritis that primarily affects the spine, causing chronic inflammation and eventual fusion of vertebrae.

bursitis: Inflammation of the bursae — small fluid-filled sacs that cushion bones, tendons, and muscles near joints.

sarcoidosis: An inflammatory disease that causes small clumps of inflammatory cells to form in various organs, most commonly the lungs.

thrombocytopenia: A condition where there are too few platelets in the blood, raising the risk of bleeding.

moonface: A rounding and puffiness of the face caused by fluid and fat redistribution — a characteristic side effect of high or prolonged corticosteroid use.

pseudotumor cerebri: Increased pressure inside the skull without a tumor, which can cause headaches and vision problems — has been associated with corticosteroid withdrawal.

striae: Stretch marks — silvery or reddish streaks on the skin that can result from prolonged corticosteroid use causing skin thinning.

contraindicated: Should not be used in that situation, because the risk is considered too high.

Adverse Reactions: Unwanted or harmful effects that people experienced while taking a medicine, listed on its official label.

anemia: A low level of red blood cells or the oxygen-carrying protein inside them, which can cause tiredness, weakness, and paleness.

autoimmune: Describes a condition in which the body's defense system mistakenly attacks its own healthy cells or tissues.

cardiac arrest: A sudden stop of the heart's pumping that cuts off blood flow to the body, which is a medical emergency.

colitis: Swelling and irritation of the inner lining of the large intestine, or colon.

contact dermatitis: A skin rash caused by touching something that irritates the skin or triggers an allergy.

depression: A lasting low mood with loss of interest that affects everyday life.

dermatitis: Inflammation of the skin, causing redness, itching, and sometimes swelling or blisters.

diarrhea: Loose, watery bowel movements that happen more often than normal.

Dosage and Administration: The label section explaining how much of a medicine to use and how to take or give it.

erythema: Redness of the skin caused by increased blood flow, often from irritation or inflammation.

erythema multiforme: A skin reaction with red, target-shaped spots, usually on the hands, arms, or face.

fungal infection: An infection caused by a fungus, such as a yeast or mold, rather than by bacteria or a virus.

gout: A type of arthritis with sudden, painful, swollen joints caused by uric acid crystals.

hemolytic anemia: A shortage of red blood cells caused by them breaking apart faster than the body can replace them.

hypersensitivity: An overreaction of the body's defense system to a substance, causing symptoms such as rash, swelling, or trouble breathing.

Indications and Usage: The label section stating which medical conditions the FDA has officially approved the medicine to treat, prevent, or manage.

insomnia: Trouble falling asleep, staying asleep, or getting restful sleep.

irritability: Getting annoyed, frustrated, or angry more easily than usual.

NDC: A unique number that identifies a specific medicine, its maker, strength, and package size.

perforation: A hole that forms all the way through the wall of the stomach or intestine.

psychosis: A state of losing touch with reality, such as seeing or hearing things that are not there or holding false beliefs.

purpura: Purple spots or patches on the skin caused by bleeding just under the surface.

remission: A period when the signs and symptoms of cancer are reduced or have disappeared.

seizure: A sudden burst of abnormal electrical activity in the brain that can cause shaking, staring, confusion, or loss of awareness.

serum sickness: A delayed reaction, usually one to two weeks after exposure, causing fever, rash, and joint pain as the body reacts to a foreign substance.

Stevens-Johnson syndrome: A rare, serious reaction causing painful blistering and peeling of the skin and the moist linings of the mouth, eyes, and other areas.

suspension: A liquid holding fine drug particles that are mixed in but not fully dissolved, so it must be shaken before use.

taper: Gradually lowering a dose in steps before stopping, rather than quitting all at once.

tuberculosis: A serious infection, usually of the lungs, caused by tuberculosis bacteria and spread through the air.

Warnings and Precautions: The label section describing serious risks to know about and safety steps to follow while using a medicine.